Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Conditions:Smoking Cessation
Therapuetic Areas:Pulmonary / Respiratory Diseases
Age Range:55 - 80
Start Date:October 10, 2017
End Date:October 2021
Contact:Jamie Ostroff, PhD

Use our guide to learn which trials are right for you!

This study is to help determine the most effective type or combination of treatments to offer
patients seeking lung cancer screening who are smokers to help them reduce the number of
cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the
benefits of lung cancer screening by providing a blue print of best practices for screening
sites to deliver tobacco treatment to their patients who are smokers, in a way that does not
add burden to screening site staff and increases the chances of patients quitting smoking.

Inclusion Criteria:

Site Eligibility (as per SC self-report)

- Must be designated as an American College of Radiology (ACR) designated lung cancer
screening site

- Reports at least one year of lung cancer screening experience

- Reports conducting at least 20 new initial screenings per month Site Coordinator (SC)
Eligibility (as per SC self-report)

- Employed as a full-time Site Coordinator at participating lung cancer screening site
Patient Eligibility (as per self-report)

- Between the ages of 55-80 years old

- Seeking baseline or annual follow-up LDCT lung cancer screening

- Have at least a 30 pack-year history of smoking

- Currently a smoker, defined as self-reported cigarette smoking (some days, every day)
within the past 30 days.

- Must be reachable by telephone

- Must be English speaking due to the study materials being available in English only
and limited available resources for translation.

Exclusion Criteria:

Patient (as per self-report)

- NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks
or, unstable/worsening angina).

- Smokers who are receiving other tobacco treatment services or have used cessation
medications (NRT, bupropion, varenicline) within the past month.
We found this trial at
Walnut Creek, California 94598
Principal Investigator: Michaela Straznicka, MD
Phone: 925-932-6330
Walnut Creek, CA
Click here to add this to my saved trials
Los Angeles, California 90033
213) 740-2311
Principal Investigator: Christopher Lee, MD
Phone: 323-442-8721
University of Southern California The University of Southern California is one of the world’s leading...
Los Angeles, CA
Click here to add this to my saved trials
Crown Point, Indiana 46307
Phone: 219-310-2550
Crown Point, IN
Click here to add this to my saved trials
Kankakee, Illinois 60901
Phone: 815-937-1237
Kankakee, IL
Click here to add this to my saved trials
259 1st Street
Mineola, New York 11501
Phone: 516-663-9500
Mineola, NY
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Jamie Ostroff, PhD
Phone: 646-888-0041
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
New York, NY
Click here to add this to my saved trials
Portland, Oregon 97210
Phone: 503-413-5702
Portland, OR
Click here to add this to my saved trials
Scarborough, Maine 04074
Phone: 207-396-7760
Scarborough, ME
Click here to add this to my saved trials